Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A

American Journal of Pathology

Volumn 181, Issue 2, 2012, Pages 693-705

  Desch, Anna ^a   Strozyk, Elwira A ^b   Bauer, Alexander T ^a   Huck, Volker ^a   Niemeyer, Verena ^a   Wieland, Thomas ^a   Schneider, Stefan W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; GELATINASE A; PADGEM PROTEIN; PROTEOME; SMALL INTERFERING RNA; VASCULOTROPIN A; VON WILLEBRAND FACTOR;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ACTIVATION; DNA FINGERPRINTING; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MELANOMA; MICE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, VITRONECTIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON WILLEBRAND FACTOR;

EID: 84864123612     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.04.012     Document Type: Article

References (55)

1. E. Atallah, L. Flaherty Treatment of metastatic malignant melanoma Curr Treat Options Oncol 6 2005 185 193
2. X.D. Zhang, J.J. Wu, S. Gillespie, J. Borrow, P. Hersey Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin Clin Cancer Res 12 2006 1355 1364
3. V.O. Melnikova, M. Bar-Eli Inflammation and melanoma metastasis Pigment Cell Melanoma Res 22 2009 257 267
4. L. Erpenbeck, M.P. Schon Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Blood 115 2010 3427 3436
5. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850
6. A.K. Kakkar, M.N. Levine, Z. Kadziola, N.R. Lemoine, V. Low, H.K. Patel, G. Rustin, M. Thomas, M. Quigley, R.C. Williamson Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 2004 1944 1948
7. A.Y. Lee, F.R. Rickles, J.A. Julian, M. Gent, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins, M.N. Levine Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism J Clin Oncol 23 2005 2123 2129
8. A. Lazo-Langner, G.D. Goss, J.N. Spaans, M.A. Rodger The effect of low-molecular-weight heparin on cancer survival: a systematic review and meta-analysis of randomized trials J Thromb Haemost 5 2007 729 737
9. L.M. Coussens, Z. Werb Inflammation and cancer Nature 420 2002 860 867
10. J.H. Im, W. Fu, H. Wang, S.K. Bhatia, D.A. Hammer, M.A. Kowalska, R.J. Muschel Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation Cancer Res 64 2004 8613 8619
11. T. Goerge, A. Barg, E.M. Schnaeker, B. Poppelmann, V. Shpacovitch, A. Rattenholl, C. Maaser, T.A. Luger, M. Steinhoff, S.W. Schneider Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation Cancer Res 66 2006 7766 7774
12. L. Borsig The role of platelet activation in tumor metastasis Expert Rev Anticancer Ther 8 2008 1247 1255
13. L. Borsig, R. Wong, R.O. Hynes, N.M. Varki, A. Varki Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci U S A 99 2002 2193 2198
14. B. Nieswandt, M. Hafner, B. Echtenacher, D.N. Mannel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1999 1295 1300
15. T. Goerge, F. Kleineruschkamp, A. Barg, E.M. Schnaeker, V. Huck, M.F. Schneider, M. Steinhoff, S.W. Schneider Microfluidic reveals generation of platelet-strings on tumor-activated endothelium Thromb Haemost 98 2007 283 286
16. S.W. Schneider, S. Nuschele, A. Wixforth, C. Gorzelanny, A. Alexander-Katz, R.R. Netz, M.F. Schneider Shear-induced unfolding triggers adhesion of von Willebrand factor fibers Proc Natl Acad Sci U S A 104 2007 7899 7903
17. A. Boire, L. Covic, A. Agarwal, S. Jacques, S. Sherifi, A. Kuliopulos PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells Cell 120 2005 303 313
18. S. Loffek, P. Zigrino, P. Angel, B. Anwald, T. Krieg, C. Mauch High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1α and basic fibroblast growth factor-mediated mechanisms J Invest Dermatol 124 2005 638 643
19. N. Kerk, E.A. Strozyk, B. Poppelmann, S.W. Schneider The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells J Invest Dermatol 130 2010 2259 2268
20. B.M. Mueller, R.A. Reisfeld, T.S. Edgington, W. Ruf Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis Proc Natl Acad Sci U S A 89 1992 11832 11836
21. A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 2007 1723 1729
22. G.N. Van Muijen, K.F. Jansen, I.M. Cornelissen, D.F. Smeets, J.L. Beck, D.J. Ruiter Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice Int J Cancer 48 1991 85 91
23. G.N. Van Muijen, L.M. Cornelissen, C.F. Jansen, C.G. Figdor, J.P. Johnson, E.B. Brocker, D.J. Ruiter Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice Clin Exp Metastasis 9 1991 259 272
24. A. Lockshin, B.C. Giovanella, P.D. De Ipolyi, L.J. Williams Jr, J.T. Mendoza, S.O. Yim, J.S. Stehlin Jr Exceptional lethality for nude mice of cells derived from a primary human melanoma Cancer Res 45 1985 345 350
25. J.W. Rak, E.J. Hegmann, C. Lu, R.S. Kerbel Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression J Cell Physiol 159 1994 245 255
26. C.F. Verschraegen, B.C. Giovanella, J.T. Mendoza, A.J. Kozielski, J.S. Stehlin Jr Specific organ metastases of human melanoma cells injected into the arterial circulation of nude mice Anticancer Res 11 1991 529 535
27. C. Aubert, F. Rouge, J.R. Galindo Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro J Natl Cancer Inst 64 1980 1029 1040
28. B. Thayaparasingham, A. Kunz, N. Peters, D. Kulms Sensitization of melanoma cells to TRAIL by UVB-induced and NF-κB-mediated downregulation of xIAP Oncogene 28 2009 345 362
29. M. Rusnati, M. Camozzi, E. Moroni, B. Bottazzi, G. Peri, S. Indraccolo, A. Amadori, A. Mantovani, M. Presta Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis Blood 104 2004 92 99
30. C. Chetty, S.S. Lakka, P. Bhoopathi, J.S. Rao MMP-2 alters VEGF expression via αvβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells Int J Cancer 127 2010 1081 1095
31. L.A. Shevde, D.R. Welch Metastasis suppressor pathways: an evolving paradigm Cancer Lett 198 2003 1 20
32. M.S. Soengas, S.W. Lowe Apoptosis and melanoma chemoresistance Oncogene 22 2003 3138 3151
33. M. Klemke, T. Weschenfelder, M.H. Konstandin, Y. Samstag High affinity interaction of integrin α4β1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers J Cell Physiol 212 2007 368 374
34. R.J. Ludwig, B. Boehme, M. Podda, R. Henschler, E. Jager, C. Tandi, W.H. Boehncke, T.M. Zollner, R. Kaufmann, J. Gille Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2004 2743 2750
35. H. Laubli, K.S. Spanaus, L. Borsig Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes Blood 114 2009 4583 4591
36. R.J. Ludwig, M.P. Schon, W.H. Boehncke P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis Expert Opin Ther Targets 11 2007 1103 1117
37. C.P. Klerk, S.M. Smorenburg, H.M. Otten, A.W. Lensing, M.H. Prins, F. Piovella, P. Prandoni, M.M. Bos, D.J. Richel, G. van Tienhoven, H.R. Buller The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2005 2130 2135
38. D.C. Damin, M.A. Rosito, P. Gus, I. Roisemberg, E. Bandinelli, G. Schwartsmann Von Willebrand factor in colorectal cancer Int J Colorectal Dis 17 2002 42 45
39. S. Karpatkin, E. Pearlstein, C. Ambrogio, B.S. Coller Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo J Clin Invest 81 1988 1012 1019
40. V. Terraube, R. Pendu, D. Baruch, M.F. Gebbink, D. Meyer, P.J. Lenting, C.V. Denis Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice J Thromb Haemost 4 2006 519 526
41. I.B. Bayer-Garner, A.J. Hough Jr, B.R. Smoller Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness Mod Pathol 12 1999 770 774
42. S. Ugurel, G. Rappl, W. Tilgen, U. Reinhold Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival J Clin Oncol 19 2001 577 583
43. J. Schoenfeld, M. Jinushi, Y. Nakazaki, D. Wiener, J. Park, R. Soiffer, D. Neuberg, M. Mihm, F.S. Hodi, G. Dranoff Active immunotherapy induces antibody responses that target tumor angiogenesis Cancer Res 70 2010 10150 10160
44. N. Muller-Hermelink, H. Braumuller, B. Pichler, T. Wieder, R. Mailhammer, K. Schaak, K. Ghoreschi, A. Yazdi, R. Haubner, C.A. Sander, R. Mocikat, M. Schwaiger, I. Forster, R. Huss, W.A. Weber, M. Kneilling, M. Rocken TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis Cancer Cell 13 2008 507 518
45. N.N. Hunder, H. Wallen, J. Cao, D.W. Hendricks, J.Z. Reilly, R. Rodmyre, A. Jungbluth, S. Gnjatic, J.A. Thompson, C. Yee Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1 N Engl J Med 358 2008 2698 2703
46. E.I. Deryugina, B. Ratnikov, E. Monosov, T.I. Postnova, R. DiScipio, J.W. Smith, A.Y. Strongin MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells Exp Cell Res 263 2001 209 223
47. C.E. Brinckerhoff, J.L. Rutter, U. Benbow Interstitial collagenases as markers of tumor progression Clin Cancer Res 6 2000 4823 4830
48. U.B. Hofmann, J.R. Westphal, E.T. Waas, J.C. Becker, D.J. Ruiter, G.N. van Muijen Coexpression of integrin α(v)β3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression J Invest Dermatol 115 2000 625 632
49. A. Vaisanen, H. Tuominen, M. Kallioinen, T. Turpeenniemi-Hujanen Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value J Pathol 180 1996 283 289
50. U.B. Hofmann, A.A. Eggert, K. Blass, E.B. Brocker, J.C. Becker Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation Cancer Res 63 2003 8221 8225
51. E.M. Schnaeker, R. Ossig, T. Ludwig, R. Dreier, H. Oberleithner, M. Wilhelmi, S.W. Schneider Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion Cancer Res 64 2004 8924 8931
52. E.I. Deryugina, L. Soroceanu, A.Y. Strongin Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis Cancer Res 62 2002 580 588
53. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, D.A. Cheresh Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3 Cell 85 1996 683 693
54. H. Nagase Cell surface activation of progelatinase A (proMMP-2) and cell migration Cell Res 8 1998 179 186
55. Y. Huang, K. Hua, X. Zhou, H. Jin, X. Chen, X. Lu, Y. Yu, X. Zha, Y. Feng Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma Cell Res 18 2008 780 791